Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
This study has been completed.
Study NCT00505037. Last updated on November 3, 2008.
Information provided by Astellas Pharma Inc
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperphosphatemia
Chronic Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Kidney Failure
Metabolic Diseases
Phosphorus Metabolism Disorders
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
ASP1585
Placebo
Sevelamer hydrochloride
Additional drug interventions recognized in this trial
Sevelamer
More general drug interventions related to this trial
Chelating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Astellas Pharma Inc
Back to top of Main Content